A detailed history of Acadian Asset Management LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Acadian Asset Management LLC holds 786,292 shares of IRWD stock, worth $2.78 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
786,292
Holding current value
$2.78 Million
% of portfolio
0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$3.93 - $7.04 $3.09 Million - $5.54 Million
786,292 New
786,292 $3.24 Million
Q2 2022

Aug 09, 2022

SELL
$11.05 - $12.72 $4,928 - $5,673
-446 Reduced 7.42%
5,562 $64,000
Q1 2022

May 12, 2022

SELL
$10.61 - $12.88 $103,139 - $125,206
-9,721 Reduced 61.8%
6,008 $75,000
Q4 2021

Feb 10, 2022

SELL
$10.86 - $13.95 $3.14 Million - $4.03 Million
-289,128 Reduced 94.84%
15,729 $183,000
Q3 2021

Nov 12, 2021

SELL
$11.92 - $13.92 $4.33 Million - $5.06 Million
-363,304 Reduced 54.37%
304,857 $3.98 Million
Q2 2021

Aug 11, 2021

BUY
$10.16 - $13.11 $4.51 Million - $5.81 Million
443,525 Added 197.44%
668,161 $8.6 Million
Q1 2021

May 11, 2021

SELL
$9.04 - $11.86 $4.16 Million - $5.46 Million
-460,255 Reduced 67.2%
224,636 $2.51 Million
Q4 2020

Feb 11, 2021

SELL
$9.05 - $12.2 $1 Million - $1.35 Million
-110,913 Reduced 13.94%
684,891 $7.8 Million
Q3 2020

Nov 09, 2020

BUY
$8.99 - $10.74 $2.53 Million - $3.02 Million
281,472 Added 54.73%
795,804 $7.16 Million
Q2 2020

Aug 12, 2020

BUY
$9.14 - $11.97 $4.68 Million - $6.13 Million
512,383 Added 26289.53%
514,332 $5.31 Million
Q1 2020

May 11, 2020

BUY
$8.58 - $14.01 $16,722 - $27,305
1,949 New
1,949 $20,000

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $542M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.